ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43 | -96.5% | 2,400 | -96.5% | 0.00% | -100.0% |
| Q1 2023 | $1,236 | +129.3% | 67,800 | +159.8% | 0.00% | 0.0% |
| Q4 2022 | $539 | -99.9% | 26,100 | -19.9% | 0.00% | -50.0% |
| Q3 2022 | $852,000 | -2.0% | 32,600 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $869,000 | +52.2% | 34,300 | +109.1% | 0.00% | +100.0% |
| Q3 2021 | $571,000 | +26.9% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $450,000 | +34.7% | 16,400 | +37.8% | 0.00% | +100.0% |
| Q1 2021 | $334,000 | -31.6% | 11,900 | -36.7% | 0.00% | -50.0% |
| Q4 2020 | $488,000 | +122.8% | 18,800 | +46.9% | 0.00% | +100.0% |
| Q3 2020 | $219,000 | -33.4% | 12,800 | -3.8% | 0.00% | 0.0% |
| Q2 2020 | $329,000 | – | 13,300 | – | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $18,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |